肺癌患者外周血中循环肿瘤细胞的快速分离与体外培养

doi:10.16288/j.yczz.16-217

遗传 ›› 2017, Vol. 39 ›› Issue (1): 66-74.doi: 10.16288/j.yczz.16-217

肺癌患者外周血中循环肿瘤细胞的快速分离与体外培养

吴文君(),王智华,王卓,邓宇亮,施奇惠()

上海交通大学系统生物医学研究院,上海200240

收稿日期:2016-06-17 修回日期:2016-10-19 出版日期:2017-01-20 发布日期:2017-12-24
作者简介:吴文君,硕士研究生,专业方向：循环肿瘤细胞快速分离与体外培养。E-mail: 1126958030@qq.com|施奇惠，教授，研究方向：微流控芯片技术的单细胞分析及临床诊断芯片。E-mail: qihuishi@sjtu.edu.cn
基金资助:
国家自然科学基金项目(81371712,81501613);上海市自然科学基金项目(13ZR1456100);高等学校博士学科点专项科研基金项目(20130073120106)

Fast isolation and ex vivo culture of circulating tumor cells from the peripheral blood of lung cancer patients

Wu Wenjun(),Wang Zhihua,Wang Zhuo,Deng Yuliang,Shi Qihui()

Shanghai Center for Systems Biomedicine, Shanghai Jiaotong University, Shanghai 200240, China

Received:2016-06-17 Revised:2016-10-19 Online:2017-01-20 Published:2017-12-24
Supported by:
the National Natural Science Foundation of China(81371712,81501613);the Natural Science Foundation of Shanghai(13ZR1456100);Research Fund for the Docoral Program of High Education of China(20130073120106)

摘要/Abstract

摘要：

循环肿瘤细胞(circulating tumor cells, CTCs)是从肿瘤病灶脱落并进入外周血液循环的处于游离状态的肿瘤细胞,代表了肿瘤病灶的分子特征,可用于对肿瘤的“液体活检”。但外周血中CTCs数目极为稀少,使得后续针对CTCs的分子与功能分析面临巨大挑战。鉴于此,本文建立了一种基于微流控芯片和免疫磁珠的能够快速从肺癌患者的外周血中分离CTCs的方法。该方法直接针对全血进行一步分离,可避免血液样本预处理及富集等过程对细胞造成的损伤,从而有效地保护CTCs的活性(>90%)。分离得到的CTCs可富集在小体积中(80 μL),实现高密度的细胞培养,完成体外扩增,扩增后的CTCs可以被进一步冻存、复苏及再次增殖培养,表明已经对患者血液中的CTCs成功建系。本文进一步对CTCs进行了基因突变(EGFR、KRAS、PIK3CA、TP53和BRAF)检测及荧光标记葡萄糖类似物(2-NBDG)摄取的功能分析,证明CTCs存在较大异质性。本研究成功实现了对外周血中稀少的CTCs进行体外培养,并对CTCs进行了基因、蛋白、功能等各个层面的分析,这对于肿瘤精准医疗具有重要的临床意义。

关键词: 循环肿瘤细胞, 微流控芯片, 体外培养, 液体活检

Abstract:

Circulating tumor cells (CTCs) are free tumor cells shed from tumor site and enter into blood circulation. CTCs represent a reliable source of tumor cells for the molecular characteristics of the original tumor. However, the extraordinary rarity of CTCs makes the subsequent molecular and functional analysis technically challenging. Here, we describe a one-step microfludics-based immunomagnetic isolation method to isolate CTCs directly from the whole blood of lung adenocarcinoma patients. This method avoids harsh sample preparation and enrichment steps, and therefore preserves the viability (>90%) of CTCs during the in vitro isolation. The isolated CTCs are enriched in small volume (80 μL) and cultured ex vivo that leads to successful ex vivo expansion. The expanded CTCs can be frozen and thawed, which shows cell line property. Genetic sequencing on EGFR、KRAS、PIK3CA、TP53 and BRAF and metabolic assay (2-NBDG) are utilized to characterize the expanded CTCs. Our results demostrated that this method is suitable for ex vivo expansion of CTCs facilitates. The genomic, proteomic and metabolic analyses of CTCs have guiding significance in tumor precise treatment.

Key words: circulating tumor cells, microfluidics, ex vivo culture, liquid biospy

吴文君, 王智华, 王卓, 邓宇亮, 施奇惠. 肺癌患者外周血中循环肿瘤细胞的快速分离与体外培养[J]. 遗传, 2017, 39(1): 66-74.

Wu Wenjun, Wang Zhihua, Wang Zhuo, Deng Yuliang, Shi Qihui. Fast isolation and ex vivo culture of circulating tumor cells from the peripheral blood of lung cancer patients[J]. Hereditas(Beijing), 2017, 39(1): 66-74.

参考文献

[1]	Chambers AF, Groom AC, MacDonald IC. Metastasis: dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer, 2002, 2(8): 563-572.
[2]	Pantel K, Alix-Panabières C, Riethdorf S. Cancer micrometastases. Nat Rev Clin Oncol, 2009, 6(6): 339-351.
[3]	Méhes G, Witt A, Kubista E, Ambros PF. Circulating breast cancer cells are frequently apoptotic. Am J Pathol, 2001, 159(1): 17-20.
[4]	Larson CJ, Moreno JG, Pienta KJ, Gross S, Repollet M, O'hara SM, Russell T, Terstappen LWMM. Apoptosis of circulating tumor cells in prostate cancer patients. Cytometry A, 2004, 62(1): 46-53.
[5]	Zhang LX, Ridgway LD, Wetzel MD, Ngo J, Yin W, Kumar D, Goodman JC, Groves MD, Marchetti D. The identification and characterization of breast cancer CTCs competent for brain metastasis. Sci Transl Med, 2013, 5(180): 180ra48
[6]	Baccelli I, Schneeweiss A, Riethdorf S, Stenzinger A, Schillert A, Vogel V, Klein C, Saini M, B?uerle T, Wallwiener M, Holland-Letz T, H?fner T, Sprick M, Scharpff M, Marmé F, Sinn HP, Pantel K, Weichert W, Trumpp A. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol, 2013, 31(6): 539-544.
[7]	Zhang Z, Shiratsuchi H, Lin J, Chen GA, Reddy RM, Azizi E, Fouladdel S, Chang AC, Lin L, Jiang H, Waghray M, Luker G, Simeone DM, Wicha MS, Beer DG, Ramnath N, Nagrath S. Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model. Oncotarget, 2014, 23: 29-31.
[8]	Yao X, Choudhury AD, Yamanaka YJ, Adalsteinsson VA, Gierahn TM, Williamson CA, Lamb CR, Taplin ME, Nakabayashi M, Chabot MS, Li T, Lee GS, Boehm JS, Kantoff PW, Hahn WC, Wittrup KD, Love JC. Functional analysis of single cells identifies a rare subset of circulating tumor cells with malignant traits. Integr Biol, 2014, 6(4): 388-398.
[9]	Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky A, Ryan P, Balis UJ, Tompkins RG, Haber DA, Toner M. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature, 2007, 450(7173): 1235-1239.
[10]	Hoshino K, Huang YY, Lane N, Huebschman M, Uhr JW, Frenkel EP, Zhang XJ. Microchip-based immunomagnetic detection of circulating tumor cells. Lab Chip, 2011, 11(20): 3449-3457.
[11]	Ozkumur E, Shah AM, Ciciliano JC, Emmink BL, Miyamoto DT, Brachtel E, Yu M, Chen PI, Morgan B, Trautwein J, Kimura A, Sengupta S, Stott SL, Karabacak NM, Barber TA, Walsh JR, Smith K, Spuhler PS, Sullivan JP, Lee RJ, Ting DT, Luo X, Shaw AT, Bardia A, Sequist LV, Louis DN, Maheswaran S, Kapur R, Haber DA, Toner M. Inertial focusing for tumor antigen-dependent and-independent sorting of rare circulating tumor cells. Sci Transl Med, 2013, 5(179): 179ra47
[12]	Chung J, Issadore D, Ullal A, Lee K, Weissleder R, Lee H. Rare cell isolation and profiling on a hybrid magnetic/size-sorting chip. Biomicrofluidics, 2013, 7(5): 54107.
[13]	Deng YL, Zhang Y, Sun S, Wang ZH, Wang MJ, Yu BQ, Czajkowsky DM, Liu BY, Li Y, Wei W, Shi QH. An integrated microfluidic chip system for single-cell secretion profiling of rare circulating tumor cells. Sci Rep, 2014, 4: 7499.
[14]	Stott SL, Hsu CH, Tsukrov DI, Yu M, Miyamoto DT, Waltman BA, Rothenberg SM, Shah AM, Smas ME, Korir GK, Floyd FP Jr, Gilman AJ, Lord JB, Winokur D, Springer S, Irimia D, Nagrath S, Sequist LV, Lee RJ, Isselbacher KJ, Maheswaran S, Haber DA, Toner M. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc Natl Acad Sci USA, 2010, 107(43): 18392-18397.
[15]	Sun S, Deng Y L. Single-cell detection of EGFR gene mutation in circulating tumor cells in lung cancer. Hereditas (Beijing), 2015, 37(12): 1251-1257.
[15]	孙帅, 邓宇亮. 肺癌循环肿瘤细胞的单细胞EGFR基因突变检测. 遗传, 2015, 37(12): 1251-1257.
[16]	Forbes T P, Kralj J G. Engineering and analysis of surface interactions in a microfluidic herringbone micromixer. Lab Chip, 2012, 12(15): 2634-2637.
[17]	O’Neil R G, Wu L, Mullani N. Uptake of a fluorescent deoxyglucose analog (2-NBDG) in tumor cells. Mol Imag Biol, 2005, 7(6): 388-392.
[18]	Kravchenko-Balasha N, Wang J, Remacle F, Levine RD, Heath JR. Glioblastoma cellular architectures are predicted through the characterization of two-cell interactions. Proc Natl Acad Sci USA, 2014, 111(17): 6521-6526.
[19]	Krebs M G, Metcalf R L, Carter L, Brady G, Blackhall FH, Dive C. Molecular analysis of circulating tumour cells-biology and biomarkers. Nat Rev Clin Oncol, 2014, 11(3): 129-144.
[20]	Yu M, Bardia A, Aceto N, Bersani F, Madden MW, Donaldson MC, Desai R, Zhu HL, Comaills V, Zheng ZL, Wittner BS, Stojanov P, Brachtel E, Sgroi D, Kapur R, Shioda T, Ting DT, Ramaswamy S, Getz G, Iafrate AJ, Benes C, Toner M, Maheswaran S, Haber DA. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility. Science, 2014, 345(6193): 216-220.
[21]	Cayrefourcq L, Mazard T, Joosse S, Solassol J, Ramos J, Assenat E, Schumacher U, Costes V, Maudelonde T, Pantel K, Alix-Panabières C. Establishment and characterization of a cell line from human circulating colon cancer cells. Cancer Res, 2015, 75(5): 892-901.
[22]	Levi J, Cheng Z, Gheysens O, Patel M, Chan CT, Wang YB, Namavari M, Gambhir SS. Fluorescent fructose derivatives for imaging breast cancer cells. Bioconjug Chem, 2007, 18(3): 628-634.
[23]	Nitin N, Carlson AL, Muldoon T, El-Naggar AK, Gillenwater A, Richards-Kortum R. Molecular imaging of glucose uptake in oral neoplasia following topical application of fluorescently labeled deoxy-glucose. Int J Cancer, 2009, 124(11): 2634-2642.
[24]	Sheth RA, Josephson L, Mahmood U. Evaluation and clinically relevant applications of a fluorescent imaging analog to fluorodeoxyglucose positron emission tomography. J Biomed Opt, 2009, 14(6): 064014.
[25]	Millon S R, Ostrander JH, Brown JQ, Raheja A, Seewaldt VL, Ramanujam N. Uptake of 2-NBDG as a method to monitor therapy response in breast cancer cell lines. Breast Cancer Rese Treat, 2011, 126(1): 55-62.
[26]	Li YY, Lu QH, Liu HL, Wang JF, Zhang PC, Liang HG, Jiang L, Wang ST. Antibody-modified reduced graphene oxide films with extreme sensitivity to circulating tumor cells. Adv Mater, 2015, 27(43): 6848-6854.
[27]	Zhang FL, Jiang Y, Liu XL, Meng JX, Zhang P, C Liu HL, Yang G, Li GN, Jiang L, Wan LJ, Hu JS, Wang ST. Hierarchical nanowire arrays as three-dimensional fractal nanobiointerfaces for high efficient capture of cancer cells. Nano Lett, 2015, 16(1): 766-772.
[28]	Zeng T, Situ B, Zheng L. Detection of circulating tumor cells and real-time personalized cancer therapy. Chin J Lab Med, 2015, 38(1): 13-15.
[28]	曾涛, 司徒博, 郑磊. 循环肿瘤细胞检测与实时个体化医疗. 中华检验医学杂志, 2015, 38(1): 13-15.
[29]	Wang ST, Wang H, Jiao J, Chen KJ, Owens GE, Kamei K, Sun J, Sherman DJ, Behrenbruch CP, Wu H, Tseng HR. Three-dimensional nanostructured substrates toward efficient capture of circulating tumor cells. Angew Chem Int Ed Engl, 2009, 48(47): 8970-8973.
[30]	Guo W, Sun YF, Pan BS, Fan J. Detection and clinical application of circulating tumor cells. Chin J Clin Lab Mgt (Electronic Edition), 2014, 2(3): 43-48.
[30]	郭玮, 孙云帆, 潘柏申, 樊嘉. 循环肿瘤细胞检测及临床应用价值. 中华临床实验室管理电子杂志, 2014, 2(3): 43-48
[31]	Zhang KL, Gao XM. The biological characteristics and significance of circulating tumor cells in patients with solid maligancies. Fudan Univ J Med Sci, 2016, 43(1): 94-98.
[31]	张凯莉, 高小妹. 循环肿瘤细胞的生物学特性及其意义. 复旦学报(医学版), 2016, 43(1): 94-98.

编辑推荐

Metrics

www.chinagene.cn
备案号：京ICP备09063187号-4
总访问:,今日访问:,当前在线:

肺癌患者外周血中循环肿瘤细胞的快速分离与体外培养

Fast isolation and ex vivo culture of circulating tumor cells from the peripheral blood of lung cancer patients

RichHTML

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 7

编辑推荐

Metrics

[1]	何祥鹏,邹秉杰,齐谢敏,陈杉,陆妍,黄青,周国华. 基于核酸等温扩增的病原微生物微流控检测技术[J]. 遗传, 2019, 41(7): 611-624.
[2]	林文慧, 邹秉杰, 宋沁馨, 周国华. 多重环介导等温扩增技术研究进展[J]. 遗传, 2015, 37(9): 899-910.
[3]	孙帅, 邓宇亮. 肺癌循环肿瘤细胞的单细胞EGFR基因突变检测[J]. 遗传, 2015, 37(12): 1251-1257.
[4]	汪维鹏，周国华. 多重等位基因特异性扩增—— 微流控芯片电泳法同时测定多个单核苷酸多态性位点[J]. 遗传, 2009, 31(2): 219-224.
[5]	侯颖，谭立新，李文蓉，牛志刚，郭志勤. 一种提高体外培养细胞中期分裂相的新方法[J]. 遗传, 2005, 27(3): 457-460.
[6]	赵永贞，郑新民，曹斌云，魏庆信，李莉，魏雁，李聚学. 一种早期胚胎体外培养新方法的建立[J]. 遗传, 2004, 26(3): 0-348.
[7]	唐娟娟，吴江林，刘金华，范义荣，朱睦元. 用整合微流控芯片系统分析黄山松RAPD片段多态性[J]. 遗传, 2003, 25(4): 419-424.